Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

An Optimized Hepatocyte-like Cells Differentiation Protocol Using Machine Learning Assisted Approach and Multi-omics Analysis [RNA-seq and ATAC-seq]

ABSTRACT: The hepatocyte is a vital cell type responsible for numerous physiological processes in the body. We developed a machine learning-based AI algorithm to monitor morphological changes in hESCs during their differentiation into mature hepatocytes.Furthermore, we developed a modified strategy that safely and efficiently produces HLCs from hESCs.

ORGANISM(S): Homo sapiens

PROVIDER: GSE243881 | GEO | 2025/12/31

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

An Optimized Hepatocyte-like Cells Differentiation Protocol Using Machine Learning Assisted Approach and Multi-omics Analysis [WGS]

Project description:The hepatocyte is a vital cell type responsible for numerous physiological processes in the body. We developed a machine learning-based AI algorithm to monitor morphological changes in hESCs during their differentiation into mature hepatocytes.Furthermore, we developed a modified strategy that safely and efficiently produces HLCs from hESCs.

2025-12-31 | GSE246556 | GEO

An Optimized Hepatocyte-like Cells Differentiation Protocol Using Machine Learning Assisted Approach and Multi-omics Analysis

Project description:This SuperSeries is composed of the SubSeries listed below.

2025-12-31 | GSE246557 | GEO

Machine learning-optimized targeted detection of alternative splicing

Project description:RNA-sequencing (RNA-seq) is widely used for analysis of alternative splicing, but in practice, has inherent biases which hinder its ability to detect and quantify splicing events. To address this, we present a targeted RNA-seq method that specifically enriches for splicing-informative junction-spanning reads. Local Splicing Variation sequencing (LSV-seq) utilizes multiplexed reverse transcription from highly scalable pools of primers anchored near splice junctions of interest. Primers are designed using Optimal Prime, a novel dedicated machine learning algorithm trained on the performance of thousands of primer sequences. LSV-seq achieves high on-target capture rates and concordance with RNA-seq, while requiring several-fold lower sequencing depth. We use LSV-seq to target events with low coverage in GTEx RNA-seq data and discover hundreds of previously hidden tissue-specific splicing events. Our results demonstrate the ability of LSV-seq to capture alternative splicing with exceptional sensitivity and highlight its potential to improve the detection of other RNA features of interest.

2024-12-27 | GSE246294 | GEO

Comparative analysis of hESCs and iPSCs-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation

Project description:Two independent protocols for deriving HLCs from hESCs and iPSCs were adopted and further characterization included immunocytochemistry, real-time RT-PCR, and in vitro functional assays. Comparative microarray-based gene expression profiling was conducted on these cells and compared to the transcriptomes of human fetal liver and adult liver progenitors. HLCs derived from hESCs and hiPSCs showed significant functional similarities, similar expression of genes important for liver physiology and common pathways. However, specific differences between the two cell types could be observed. Total RNA obtained from undifferentiated hESCs, iPSCs, HLCs (hepatocyte-like cells)-derived from hESCs and iPSCs, fetal forskin fibroblasts and fetal liver.

2011-01-20 | E-GEOD-25744 | biostudies-arrayexpress

Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells

Project description:Examine characteristics of hESCs and hiPSCs during directed in-vitro differentiation into HLCs.

2017-05-24 | GSE76998 | GEO

RNA-sequencing of hepatocyte-like cells (HLCs) and primary human hepatocytes (PHHs)

Project description:The purpose of this experiment was to compared the transcriptome of hepatocyte-like cells (HLCs) generated in vitro and adult primary human hepatocytes (PHHs). HLCs were differentiated from either hESCs or hIPSCs using previously established protocols (Hannah et al 2013; Segeritz et al 2018). Undifferentiated hIPSCs were used as control to confirm differentiation status. PHHs were commercially sourced as well as freshly isolated from donors.

2022-08-11 | E-MTAB-10634 | biostudies-arrayexpress

Comparative analysis of hESCs and iPSCs-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation

2011-01-20 | GSE25744 | GEO

Simulation-assisted machine learning.

Project description:MotivationIn a predictive modeling setting, if sufficient details of the system behavior are known, one can build and use a simulation for making predictions. When sufficient system details are not known, one typically turns to machine learning, which builds a black-box model of the system using a large dataset of input sample features and outputs. We consider a setting which is between these two extremes: some details of the system mechanics are known but not enough for creating simulations that can be used to make high quality predictions. In this context we propose using approximate simulations to build a kernel for use in kernelized machine learning methods, such as support vector machines. The results of multiple simulations (under various uncertainty scenarios) are used to compute similarity measures between every pair of samples: sample pairs are given a high similarity score if they behave similarly under a wide range of simulation parameters. These similarity values, rather than the original high dimensional feature data, are used to build the kernel.ResultsWe demonstrate and explore the simulation-based kernel (SimKern) concept using four synthetic complex systems-three biologically inspired models and one network flow optimization model. We show that, when the number of training samples is small compared to the number of features, the SimKern approach dominates over no-prior-knowledge methods. This approach should be applicable in all disciplines where predictive models are sought and informative yet approximate simulations are available.Availability and implementationThe Python SimKern software, the demonstration models (in MATLAB, R), and the datasets are available at https://github.com/davidcraft/SimKern.Supplementary informationSupplementary data are available at Bioinformatics online.

| S-EPMC6792064 | biostudies-literature

Cellular models of hepatogenesis using embryonic stem cells

Project description:Induced pluripotent stem cells (iPSCs) and human embryonic stem cells (hESCs) can be differentiated into hepatocyte-like cells (HLCs) and thus provide a defined and renewable source for toxicology and regenerative medicine. Critical comparison of patient-specific iPSCs to the golden standard—hESCs will provide an assessment of their strengths and weaknesses. This dataset consists of data at the transcriptional level during the differentiation process of hESCs into HLCs including the definite endoderm (DE) and hepatic endoderm (HE) stages. Besides for the study of this in-vitro-hepatogenesis model, it can be used as reference for investigating the differences and similarities between iPSC and hESC cellular models during hepatogenesis.

2018-01-16 | GSE100447 | GEO

AI-assisted Drug Re-purposing for Human Liver Fibrosis

Project description:Liver fibrosis is a severe disease with few treatment options due to the poor quality of the available animal and in vitro models. To address this, human hepatic organoids were grown in microwells (i.e., microHOs) to provide a robust, live cell imaging platform for serially evaluating the anti-fibrotic effects of drug candidates. Here, we developed a multi-parameter image analysis workflow that enabled anti-fibrotic efficacy and drug toxicity to be serially assessed in microHOs, and endpoint analyses (flow cytometry and scRNA-Seq) were used to characterize drug effects on different cell types. Transcriptomic analysis revealed that the efficacy of five anti-fibrotic agents occurred via two different mechanisms: two inhibited TGF-induced intracellular signaling while three altered TGF-induced mesenchymal cell differentiation. microHO data facilitated drug re-purposing by enabling the effects of different drugs to be directly compared. This study provides a first demonstration that a hypothesis generating multi-agent AI system (AI co-scientist) can assist in re-purposing drugs for a disease with few treatment options. Two of three AI co-scientist-recommended drugs targeting epigenomic modifiers exhibited significant anti-fibrotic activity; and one is an FDA-approved drug (Vorinostat) that also promoted liver parenchymal cell regeneration. Hence, the use of AI co-scientist coupled with this enhanced microHO platform identified a new generation of liver fibrosis treatments that also promote liver regeneration.

2025-12-10 | GSE306096 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data